Services
LongEVity Bioscience provides a wide range of qualified services for exosome isolation, characterization, engineering, custom productions and many others through HansaBioMed Life Sciences, the specialized entity of Exosomics Group
Exosomes from selected plant sources
We isolate exosomes from a number of high quality plant (and non plant) sources, included but not limited to plants grown in controlled and organic manner, plants grown in-vitro, plant stem-cells grown in vitro (calli or meristematic stem cells) or in bioreactors, hairy roots, etc.
Exosomes concentrate and protect from degradation plant actives, microelements and grow factors.
Exosomes isolation and characterization
We can totally quarantee that our exosomes are indeed pure exosomes and not simple plant extracts!
The isolation process is executed with the most advanced technologies including different filtration steps (centrigugation and tangential flow filtration with our proprietary TFF hollow fiber filters).
Our exosomes are fully characterized by different methods including: TEM and ultramicroscopy for morfology; NTA and nano flow cytometry for size and quantity determination; immunoassays for plant exosome specific biomarkers; advanced analytics (OMICS). They can also be tested for activity with several enzimatic or cell based efficacy assays.
Exosomes can be provided in liquid, lyophilized or spray dried form according to customers needs.
Engineering, custom production, processes development
We can support your science driven innovation with specialized services such as exosomes engineering, loading or decoration.
We can assist your Company with the development of innovative and high quality ingredients or finished products.
We can support your company in defining and setting set up processes for exosomes production, customly designed on your needs.
Partnering and Pilot Projects
We help Companies achieving their R&D goals supporting them with advanced services and Pilot Projects.
Address Purity: Achieve >95 % Purity, Eliminate non-EV contaminants.
Address Heterogeneity: NTA, nFCM, and OMIC Profiling for IND-Ready Data.
Address Pilot Manufacturing: Bridging the Gap from Bench to Scalable Exosome Production.
Address cargo loading: Efficient, stable loading of RNA or protein payloads.
Address clinical readiness: Align your process with MISEV guidelines for reproducible, GMP-compliant pilot studies.